C.R. Bard gains clearance for biliary stent
Interventional equipment vendor C.R. Bard received 510(k) clearance this month from the Food and Drug Administration for its Memotherm Flexx biliary stent. The stent is used for treating malignant biliary obstructions, and will be marketed through Murray
Interventional equipment vendor C.R. Bard received 510(k) clearance this month from the Food and Drug Administration for its Memotherm Flexx biliary stent. The stent is used for treating malignant biliary obstructions, and will be marketed through Murray Hill, NJ-based Bards peripheral technologies division. The stent is available in diameters from 6 to 12 mm and lengths of 20 to 120 mm.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
